In the gravid human uterus, oxytocin induces smooth muscle cell contraction via transient receptor potential vanilloid 4 channel activation.

Summary

Using human myometrial tissue and primary smooth muscle cells, the study shows that oxytocin-induced calcium influx and contraction require TRPV4 activation and OXTR–TRPV4 proximity. Tissues from oxytocin-resistant uterine atony exhibit reduced glycosylated OXTR and diminished OXTR–TRPV4 colocalization, revealing a novel mechanism for uterine atony.

Key Findings

• TRPV4 and OXTR colocalize within <40 nm in human myometrial smooth muscle cells.
• TRPV4 antagonism or siRNA knockdown abolishes oxytocin-induced Ca2+ influx and contraction.
• Voltage-gated calcium channel blockade does not blunt oxytocin-induced calcium transients.
• Oxytocin-resistant uterine atony tissue shows reduced glycosylated OXTR and diminished OXTR–TRPV4 proximity.

Clinical Implications

TRPV4 modulators could be explored to enhance uterine tone in atony or to suppress premature contractions. The findings also inform personalized oxytocin responsiveness and potential biomarkers (glycosylated OXTR, OXTR–TRPV4 proximity).

Limitations

• Sample size and detailed patient-level data are not specified in the abstract.
• Ex vivo and cellular assays without interventional clinical outcomes; generalizability limited to term non-labouring cesarean cohort.

Future Directions

Quantify TRPV4/OXTR alterations across obstetric phenotypes, develop selective TRPV4 modulators, and test efficacy/safety in preclinical uterine contractility models followed by early-phase clinical trials.